Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	MAP1A CCDC146 FIGNL2 TACC2 DNAJB13 DNAAF2 TTBK2 KIF3B MAP1S KASH5 STARD9 NINL CFAP74 ARHGEF2 BRSK1 PARD3 STAG2 CDK2 CDK5 FOXJ1	3.54e-07	720	152	20	GO:0000226
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	CACNA1B NPR2 EPS8L2 HIP1R LYAR TUB ANKRD27 SHANK3 HNRNPK NEDD9 MSX2 CRACD TTBK2 SETDB2 MYLK3 LMAN1 NFATC2 AHNAK TMEM30A ATM MMP3 PARD3 TNXB HSPA5 MARCKS CUX1 CDK2	2.33e-06	1366	152	27	GO:0051130
GeneOntologyBiologicalProcess	organelle assembly	VPS11 TBC1D9B STBD1 CCDC146 SOX30 PATL1 SHANK3 DNAJB13 DNAAF2 TTBK2 TBC1D10B KIF3B MYLK3 KASH5 STARD9 CFAP74 ATM ARHGEF2 ULK2 STAG2 CDK2 FOXJ1	3.18e-05	1138	152	22	GO:0070925
GeneOntologyBiologicalProcess	microtubule-based process	MAP1A CCDC146 FIGNL2 TACC2 TUB DNAJB13 DNAAF2 TTBK2 KIF3B MAP1S KASH5 STARD9 NINL CFAP74 ARHGEF2 BRSK1 PARD3 STAG2 CDK2 CDK5 FOXJ1	3.35e-05	1058	152	21	GO:0007017
GeneOntologyCellularComponent	microtubule organizing center	EPS8L2 CCDC146 RPS7 CDH23 IRS1 TACC2 RPP25 NEDD9 DNAAF2 TTBK2 MYOF KIF3B MAP1S STARD9 NINL ATM BRSK1 MARCKS CDK2	4.36e-05	919	153	19	GO:0005815
GeneOntologyCellularComponent	dendrite	CACNA1B OPN4 MAP1A RASGRF1 FXR2 HIP1R NFASC SHANK3 HNRNPK CACNG8 KIF3B MAP1S MMP3 ARHGEF2 HSPA5 MARCKS CDK5	1.88e-04	858	153	17	GO:0030425
GeneOntologyCellularComponent	dendritic tree	CACNA1B OPN4 MAP1A RASGRF1 FXR2 HIP1R NFASC SHANK3 HNRNPK CACNG8 KIF3B MAP1S MMP3 ARHGEF2 HSPA5 MARCKS CDK5	1.93e-04	860	153	17	GO:0097447
GeneOntologyCellularComponent	cilium	NPR2 OPN4 MAP1A CDH23 IRS1 LYAR EFHB TUB SHANK3 DNAJB13 NEDD9 DNAAF2 TTBK2 KIF3B CFAP74 TTLL10 MARCKS	3.19e-04	898	153	17	GO:0005929
HumanPheno	Decreased fertility in females	AGPAT2 CDH23 ZFPM2 DNAJB13 DNAAF2 KASH5 CFAP74 FOXJ1	3.75e-06	104	47	8	HP:0000868
Domain	MAP1	MAP1A MAP1S	1.91e-04	3	150	2	IPR026074
Domain	Ca/CaM-dep_Ca-dep_prot_Kinase	EFHB MYLK3 NIM1K BRSK1 ULK2	2.32e-04	69	150	5	IPR020636
Domain	KH_1	FXR2 HNRNPK FUBP1 HDLBP	2.39e-04	38	150	4	PF00013
Domain	-	FXR2 HNRNPK FUBP1 HDLBP	2.64e-04	39	150	4	3.30.1370.10
Domain	KH	FXR2 HNRNPK FUBP1 HDLBP	2.92e-04	40	150	4	SM00322
Domain	KH_dom	FXR2 HNRNPK FUBP1 HDLBP	2.92e-04	40	150	4	IPR004087
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FAM193B TBC1D9B ZBTB4 AGPAT2 HIP1R IRS1 ZNF236 GTF2IRD1 C2CD2 FAM83H HIVEP3 MSX2 MYOF ZNF263 SLC38A10 EHBP1L1 MAP1S SH3TC1 ADAMTS7 CDK13 AHNAK NINL ARHGEF2 SNAPC4 CABIN1 ULK2 RAI1	5.26e-13	1105	154	27	35748872
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	DIDO1 PATL1 GTF2IRD1 PALB2 HNRNPK MYOF TBC1D10B EEF2 PAXBP1 MAP1S CDK13 FUBP1 ZFP91 ATM ARHGEF2 SNAPC4 PARD3 STAG2 FKBP5 CDK2 HDLBP	3.83e-11	774	154	21	15302935
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	IQSEC3 SRSF1 FXR2 NFASC DIDO1 PLA2G15 SHANK3 HNRNPK FAM171A1 ZNF263 EEF2 KIF3B UBR5 GPR158 ARHGEF2 BRSK1 PARD3 CABIN1 FOXG1 CUX1 RAI1 CDK5	3.30e-10	963	154	22	28671696
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SRSF1 BAZ2B STRBP RPS7 NOL6 RSF1 DIDO1 EIF2S3B LYAR HNRNPK EEF2 HOXB9 PAXBP1 FUBP1 AHNAK HTATSF1 HSPA5 STAG2 CUX1 RAI1 HDLBP	1.67e-09	954	154	21	36373674
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	BAZ2B INPP5D DIDO1 PALB2 HNRNPK GPALPP1 EEF2 ARNT LMAN1 UBR5 CDK13 FUBP1 ZFP91 ARHGEF2 STAG2 FKBP5 CUX1 RAI1 CDK2 HDLBP	1.02e-07	1103	154	20	34189442
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SRSF1 FXR2 RPS7 DIDO1 EIF2S3B TACC2 PATL1 LYAR HNRNPK EEF2 PAXBP1 MAP1S UBR5 CDK13 AHNAK HTATSF1 ARHGEF2 HSPA5 STAG2 MARCKS CDK2 HDLBP	3.15e-07	1415	154	22	28515276
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	SRSF1 FXR2 RPS7 NOL6 DIDO1 PATL1 LYAR ANKRD27 ZCCHC3 HNRNPK FAM83H GPALPP1 EEF2 PAXBP1 LMAN1 FUBP1 AHNAK ARHGEF2 HSPA5 FKBP5 CDK2	4.04e-07	1318	154	21	30463901
Pubmed	A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.	VPS11 FXR2 STRBP DAP ZCCHC3 FAM83H CRACD LMAN1 PDLIM1 AHNAK ZFP91 HSPA5 HDLBP	4.26e-07	503	154	13	36217030
Pubmed	VCP phosphorylation-dependent interaction partners prevent apoptosis in Helicobacter pylori-infected gastric epithelial cells.	TBC1D9B GGA2 HIP1R LYAR TBC1D10B UBR5 ARHGEF2 HSPA5 STAG2 HDLBP	6.98e-07	288	154	10	23383273
Pubmed	Genome-Wide Meta-Analysis Identifies Multiple Novel Rare Variants to Predict Common Human Infectious Diseases Risk.	INPP5D RSF1 MACROD2	8.46e-07	5	154	3	37108169
Pubmed	mTORC2 interactome and localization determine aggressiveness of high-grade glioma cells through association with gelsolin.	SRSF1 HNRNPK MYOF EEF2 KIF3B LMAN1 AHNAK ARHGEF2 HSPA5 HDLBP	1.44e-06	312	154	10	37120454
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	SRSF1 FXR2 RPS7 DIDO1 LYAR TBC1D10B AHNAK ZFP91 STAG2 CUX1 RAI1	1.62e-06	394	154	11	27248496
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	CYP1B1 TBC1D9B FXR2 STRBP NOL6 AGPAT2 LYAR CRACD MYOF EEF2 PDLIM1 UBR5 AHNAK ATM ARHGEF2 CABIN1 STAG2 FKBP5 CUX1 CDK2 CDK5	1.66e-06	1440	154	21	30833792
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	SRSF1 MAP1A FXR2 IRS1 ZCCHC3 PDLIM1 UBR5 FUBP1 ZNF264 HDLBP	2.19e-06	327	154	10	15592455
Pubmed	Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.	FXR2 NEDD9 PDLIM1 NFATC2 CDK13 PARD3 CDK2	2.27e-06	133	154	7	15144186
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	FXR2 STRBP RPS7 NOL6 DIDO1 HNRNPK AHNAK HSPA5 HDLBP	3.67e-06	271	154	9	32433965
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SRSF1 BAZ2B RPS7 AGPAT2 DIDO1 LYAR GTF2IRD1 PALB2 HNRNPK ARNT PAXBP1 CDK13 AHNAK HTATSF1 CABIN1 HSPA5 STAG2 CUX1 RAI1	4.93e-06	1294	154	19	30804502
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RASGRF1 FXR2 CDH23 DIDO1 HNRNPK MAP1S CDK13 ZFP91 HTATSF1 GNGT2	5.24e-06	361	154	10	26167880
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SRSF1 MAP1A RPS7 AGPAT2 DIDO1 LYAR GTF2IRD1 HNRNPK TBC1D10B EEF2 EHBP1L1 PAXBP1 ATM ARHGEF2 TNXB HSPA5 MARCKS	6.72e-06	1082	154	17	38697112
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	FXR2 STRBP RPS7 NOL6 RSF1 DIDO1 ZCCHC3 UBR5 AHNAK ATM STAG2 RAI1 HDLBP	7.45e-06	653	154	13	22586326
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	EPS8L2 HNRNPK FAM83H TBC1D10B EEF2 EHBP1L1 PDLIM1 AHNAK PARD3 HSPA5 MARCKS HDLBP	8.91e-06	565	154	12	25468996
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	CACNA1B STRBP TUB HNRNPK GPALPP1 TBC1D10B THBS1 EEF2 GPR158 PARD3 HDLBP	9.58e-06	475	154	11	31040226
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	FAM193B GTF2IRD1 FAM83H MAP1S UBR5 FOXG1 MARCKS CDK5	9.82e-06	232	154	8	25515538
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	SRSF1 FXR2 RPS7 IRS1 PATL1 HNRNPK FAM83H MYOF EEF2 HOXB9 ARNT PAXBP1 ARHGEF2 PARD3 HSPA5 FKBP5 CUX1 HDLBP	1.12e-05	1247	154	18	27684187
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MED30 RSF1 DIDO1 LYAR EEF2 UBR5 CDK13 FUBP1 AHNAK ZFP91 HTATSF1 ATM STAG2 FKBP5 CDK2 CDK5	1.21e-05	1014	154	16	32416067
Pubmed	SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.	COL4A2 FXR2 RPS7 HNRNPK THBS1 EEF2 HSPA5	1.28e-05	173	154	7	23979707
Pubmed	Strain background effects and genetic modifiers of hearing in mice.	MAP1A CDH23 TUB	1.37e-05	11	154	3	16579977
Pubmed	Functional proteomics mapping of a human signaling pathway.	COL4A2 STBD1 ANKRD27 ZNF518A NEDD9 ARNT KIF3B UBR5 CDK13 POLI HTATSF1 HDLBP	1.39e-05	591	154	12	15231748
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	STBD1 RPS7 HNRNPK FAM171A1 TBC1D10B EEF2 LMAN1 PDLIM1 AHNAK PARD3 HSPA5 MARCKS HDLBP	1.75e-05	708	154	13	39231216
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	SRSF1 FXR2 STRBP RPS7 NOL6 LYAR HNRNPK PAXBP1 HTATSF1 HSPA5 CUX1 RAI1	1.75e-05	605	154	12	28977666
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	BAZ2B RSF1 DIDO1 LYAR SETDB2 HOXB9 ZFP91 SNAPC4 CABIN1 STAG2 CUX1 RAI1	1.84e-05	608	154	12	36089195
Pubmed	Pooled-matrix protein interaction screens using Barcode Fusion Genetics.	GGA2 FAM90A1 HNRNPK NEDD9 ARNT KASH5 CBY2 ATM CDK2 CDK5	1.90e-05	419	154	10	27107012
Pubmed	Genetic modification of hearing in tubby mice: evidence for the existence of a major gene (moth1) which protects tubby mice from hearing loss.	MAP1A TUB	1.95e-05	2	154	2	10441341
Pubmed	ATM induces MacroD2 nuclear export upon DNA damage.	MACROD2 ATM	1.95e-05	2	154	2	28069995
Pubmed	Regulation of N-type voltage-gated calcium channels and presynaptic function by cyclin-dependent kinase 5.	CACNA1B CDK5	1.95e-05	2	154	2	22920258
Pubmed	Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver.	RSF1 IRS1	1.95e-05	2	154	2	19475691
Pubmed	STAG2 Regulates Homologous Recombination Repair and Sensitivity to ATM Inhibition.	ATM STAG2	1.95e-05	2	154	2	37985839
Pubmed	Neuronal nuclear organization is controlled by cyclin-dependent kinase 5 phosphorylation of Ras Guanine nucleotide releasing factor-1.	RASGRF1 CDK5	1.95e-05	2	154	2	16921254
Pubmed	Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling.	CDK2 CDK5	1.95e-05	2	154	2	9126296
Pubmed	NFAT1 promotes cell motility through MMP-3 in esophageal squamous cell carcinoma.	NFATC2 MMP3	1.95e-05	2	154	2	28024290
Pubmed	Microtubule-associated protein 1 A and tubby act independently in regulating the localization of stereocilin to the tips of inner ear hair cell stereocilia.	MAP1A TUB	1.95e-05	2	154	2	36104704
Pubmed	The activation and inhibition of cyclin-dependent kinase-5 by phosphorylation.	CDK2 CDK5	1.95e-05	2	154	2	17713927
Pubmed	Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.	PALB2 ATM	1.95e-05	2	154	2	23561644
Pubmed	The Ras guanine nucleotide exchange factor RasGRF1 promotes matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue.	RASGRF1 MMP3	1.95e-05	2	154	2	19678938
Pubmed	Insulin sensitivity of glucose disposal and lipolysis: no influence of common genetic variants in IRS-1 and CAPN10.	IRS1 CAPN10	1.95e-05	2	154	2	12107745
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	SRSF1 FXR2 STRBP RPS7 LYAR ZCCHC3 HNRNPK EEF2 FUBP1 HSPA5	1.98e-05	421	154	10	34650049
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	STRBP RPS7 NOL6 RSF1 PALB2 GPALPP1 EEF2 CDK13 STARD9 FUBP1 AHNAK CFAP74 ATM ARHGEF2 PLIN1 HSPA5 STAG2 CUX1 RAI1	2.24e-05	1442	154	19	35575683
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	SRSF1 FXR2 RPS7 NOL6 EIF2S3B LYAR HNRNPK NEDD9 TBC1D10B EEF2 CDK13 AHNAK ZFP91 ARHGEF2 HSPA5	2.25e-05	949	154	15	36574265
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	DIDO1 TACC2 HNRNPK GPALPP1 FUBP1 AHNAK	2.59e-05	130	154	6	35545047
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	CYP1B1 DIDO1 IRS1 THBS1 ARNT POLI ATM MMP3 CDK5	2.88e-05	351	154	9	20453000
Pubmed	Roles of tau protein in health and disease.	MAP1A TTBK2 BRSK1 CDK5	2.98e-05	40	154	4	28386764
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ALLC STRBP CRACD HOXB9 ARNT SH3TC1 NFATC2 UBR5 ARHGEF2 CABIN1 STAG2 FOXG1 CUX1 FOXJ1	2.99e-05	857	154	14	25609649
Pubmed	FOXG1 sequentially orchestrates subtype specification of postmitotic cortical projection neurons.	ZFPM2 FOXG1 CUX1	2.99e-05	14	154	3	35613274
Pubmed	The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization.	INPP5D EIF2S3B HNRNPK NEDD9 FKBP5	3.12e-05	81	154	5	20697350
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BDP1 FRMPD2 NFASC DAP PATL1 ZNF236 GTF2IRD1 C2CD2 HIVEP3 SH3TC1 GPR158 CDK13 FUBP1 PARD3 TMCC1 STAG2 FKBP5 CUX1 RAI1	3.46e-05	1489	154	19	28611215
Pubmed	Cdk12 Regulates Neurogenesis and Late-Arising Neuronal Migration in the Developing Cerebral Cortex.	ATM CUX1 CDK5	3.73e-05	15	154	3	27073218
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SRSF1 FXR2 STRBP NOL6 DIDO1 PATL1 LYAR TBC1D10B EEF2 PAXBP1 CDK13 STARD9 AHNAK ZFP91 ARHGEF2 PARD3 MARCKS HDLBP	3.91e-05	1371	154	18	36244648
Pubmed	Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.	RPS7 NFASC HNRNPK PDLIM1 AHNAK ARHGEF2 HSPA5 MARCKS	4.28e-05	285	154	8	21423176
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	SRSF1 FXR2 RPS7 NOL6 DIDO1 LYAR ZCCHC3 HNRNPK FAM83H MYOF THBS1 EEF2 AHNAK ARHGEF2 HSPA5 MARCKS HDLBP	4.52e-05	1257	154	17	36526897
Pubmed	A primary expression map of the chromosome 15q15 region containing the recessive form of limb-girdle muscular dystrophy (LGMD2A) gene.	MAP1A THBS1 STARD9	4.57e-05	16	154	3	7633422
Pubmed	Modifier genes and protective alleles in humans and mice.	MAP1A CDH23 TUB	4.57e-05	16	154	3	12787792
Pubmed	Stalled replication forks within heterochromatin require ATRX for protection.	ATM FOXG1 CUX1	4.57e-05	16	154	3	27171262
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	STBD1 CHML C2CD2 LMAN1 PDLIM1 UBR5 AHNAK MARCKS CUX1 CDK2 HDLBP	4.92e-05	568	154	11	37774976
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	EPS8L2 MAP1A RPS7 NOL6 HIP1R DIDO1 DNAAF2 ZFP91 CUX1 CDK2	5.19e-05	472	154	10	38943005
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX30 ZBTB4 DRGX ZNF236 ZFPM2 HIVEP3 MSX2 HOXB9 ARNT NFATC2 SNAPC4 EN2 FOXG1 FOXJ1	5.57e-05	908	154	14	19274049
Pubmed	Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage.	FXR2 RPS7 GTF2IRD1 PALB2 GCC1 BRSK1	5.57e-05	149	154	6	25184681
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	RPS7 HNRNPK EEF2 FUBP1 AHNAK HTATSF1 HSPA5 MARCKS CUX1 HDLBP	5.67e-05	477	154	10	31300519
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF15 SRSF1 TACC2 PATL1 HNRNPK FAM83H TTBK2 THBS1 PAXBP1 MAP1S UBR5 AHNAK HTATSF1 ATM STAG2 CDK5	5.78e-05	1155	154	16	20360068
Pubmed	ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage.	HNRNPK ATM	5.83e-05	3	154	2	23343766
Pubmed	Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis.	THBS1 FUBP1	5.83e-05	3	154	2	31587040
Pubmed	Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.	PALB2 ATM	5.83e-05	3	154	2	32996020
Pubmed	Gene expression analyses on embryonic external genitalia: identification of regulatory genes possibly involved in masculinization processes.	CYP1B1 FKBP5	5.83e-05	3	154	2	18452486
Pubmed	GRP78 activates the Wnt/HOXB9 pathway to promote invasion and metastasis of hepatocellular carcinoma by chaperoning LRP6.	HOXB9 HSPA5	5.83e-05	3	154	2	31310747
Pubmed	CDC2L5, a Cdk-like kinase with RS domain, interacts with the ASF/SF2-associated protein p32 and affects splicing in vivo.	SRSF1 CDK13	5.83e-05	3	154	2	16721827
Pubmed	RNA expressions of AHR, ARNT and CYP1B1 are influenced by AHR Arg554Lys polymorphism.	CYP1B1 ARNT	5.83e-05	3	154	2	21742528
Pubmed	TIGAR regulates DNA damage and repair through pentosephosphate pathway and Cdk5-ATM pathway.	ATM CDK5	5.83e-05	3	154	2	25928429
Pubmed	Differential regulation of CDP/Cux p110 by cyclin A/Cdk2 and cyclin A/Cdk1.	CUX1 CDK2	5.83e-05	3	154	2	16081423
Pubmed	Phosphorylation of hnRNP K by cyclin-dependent kinase 2 controls cytosolic accumulation of TDP-43.	HNRNPK CDK2	5.83e-05	3	154	2	25410660
Pubmed	Factors that differentiate cancer risk management decisions among females with pathogenic/likely pathogenic variants in PALB2, CHEK2, and ATM.	PALB2 ATM	5.83e-05	3	154	2	37515473
Pubmed	Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM/Chk1/cdc25 pathway in human osteosarcoma cells.	RASGRF1 ATM	5.83e-05	3	154	2	17611684
Pubmed	PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.	PALB2 ATM	5.83e-05	3	154	2	27595995
Pubmed	CDK13, a new potential human immunodeficiency virus type 1 inhibitory factor regulating viral mRNA splicing.	SRSF1 CDK13	5.83e-05	3	154	2	18480452
Pubmed	EDD inhibits ATM-mediated phosphorylation of p53.	UBR5 ATM	5.83e-05	3	154	2	21383020
Pubmed	[Effect of the Gly972Arg, SNP43 and Prol2Ala polymorphisms of the genes IRS1, CAPN10 and PPARG2 on secondary failure to sulphonylurea and metformin in patients with type 2 diabetes in Yucatán, México].	IRS1 CAPN10	5.83e-05	3	154	2	19418728
Pubmed	ADAMTS-7 inhibits re-endothelialization of injured arteries and promotes vascular remodeling through cleavage of thrombospondin-1.	THBS1 ADAMTS7	5.83e-05	3	154	2	25712208
Pubmed	Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.	STRBP UBR5	5.83e-05	3	154	2	38280476
Pubmed	Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India.	IRS1 CAPN10	5.83e-05	3	154	2	24612564
Pubmed	Cut-like homeobox 1 and nuclear factor I/B mediate ENGRAILED2 autism spectrum disorder-associated haplotype function.	EN2 CUX1	5.83e-05	3	154	2	22180456
Pubmed	NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.	NFATC2 MMP3	5.83e-05	3	154	2	27013197
Pubmed	Searching for novel Cdk5 substrates in brain by comparative phosphoproteomics of wild type and Cdk5-/- mice.	MARCKS CDK5	5.83e-05	3	154	2	24658276
Pubmed	An allele of microtubule-associated protein 1A (Mtap1a) reduces photoreceptor degeneration in Tulp1 and Tub Mutant Mice.	MAP1A TUB	5.83e-05	3	154	2	22323461
Pubmed	UBR5-mediated ubiquitination of ATMIN is required for ionizing radiation-induced ATM signaling and function.	UBR5 ATM	5.83e-05	3	154	2	25092319
Pubmed	The transcriptional transactivator Tat selectively regulates viral splicing.	SRSF1 HTATSF1	5.83e-05	3	154	2	19966273
Pubmed	Microtubule-associated protein 1A is a modifier of tubby hearing (moth1).	MAP1A TUB	5.83e-05	3	154	2	11925566
Pubmed	Benzyl butyl phthalate induces necrosis by AhR mediation of CYP1B1 expression in human granulosa cells.	CYP1B1 ARNT	5.83e-05	3	154	2	22138065
Pubmed	Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.	PALB2 ATM	5.83e-05	3	154	2	27464310
Pubmed	Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes.	CDK2 CDK5	5.83e-05	3	154	2	8275715
Pubmed	CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.	CDK2 CDK5	5.83e-05	3	154	2	26464264
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	EPS8L2 SRSF1 HIP1R HNRNPK FUBP1 AHNAK ATM ARHGEF2 HSPA5 STAG2 HDLBP	6.11e-05	582	154	11	20467437
Pubmed	Identification of DeltaNp63alpha protein interactions by mass spectrometry.	MAP1A ZBTB4 HNRNPK HSPA5	6.18e-05	48	154	4	20085233
Interaction	TOP3B interactions	FAM193B TBC1D9B FXR2 ZBTB4 AGPAT2 HIP1R IRS1 PATL1 LYAR ZNF236 GTF2IRD1 C2CD2 FAM83H HIVEP3 MSX2 MYOF ZNF263 SLC38A10 EHBP1L1 MAP1S SH3TC1 ADAMTS7 CDK13 AHNAK NINL ARHGEF2 SNAPC4 CABIN1 ULK2 HSPA5 RAI1 HDLBP	4.86e-08	1470	153	32	int:TOP3B
Interaction	SMC5 interactions	SRSF1 BAZ2B STRBP RPS7 NOL6 RSF1 DIDO1 EIF2S3B LYAR HNRNPK EEF2 HOXB9 PAXBP1 FUBP1 AHNAK HTATSF1 HSPA5 STAG2 CUX1 RAI1 HDLBP	2.27e-05	1000	153	21	int:SMC5
Interaction	CEBPA interactions	RASGRF1 BAZ2B INPP5D NOL6 DIDO1 PALB2 HNRNPK GPALPP1 MSX2 EEF2 ARNT LMAN1 UBR5 CDK13 FUBP1 ZFP91 ARHGEF2 HSPA5 STAG2 FKBP5 CUX1 RAI1 CDK2 HDLBP	2.28e-05	1245	153	24	int:CEBPA
Interaction	DRGX interactions	DRGX MSX2 EN2	2.34e-05	8	153	3	int:DRGX
Cytoband	15q24.2	RASGRF1 RPP25 ADAMTS7	1.71e-04	32	154	3	15q24.2
GeneFamily	Cyclin dependent kinases	CDK13 CDK2 CDK5	3.67e-04	26	98	3	496
GeneFamily	PDZ domain containing	FRMPD2 SHANK3 PDLIM1 AHNAK PARD3	1.43e-03	152	98	5	1220
GeneFamily	PHD finger proteins	BAZ2B RSF1 DIDO1 PYGO2	1.45e-03	90	98	4	88
GeneFamily	Zinc fingers CXXC-type\|Methyl-CpG binding domain containing	BAZ2B SETDB2	1.55e-03	11	98	2	1025
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 MSX2 MYOF GJB3 HOXB9 FCGBP KIAA1755 FOXJ1	3.23e-07	189	154	8	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 MARCKS FOXJ1	3.36e-07	190	154	8	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INPP5D PCDH12 ITGA9 SHANK3 HIVEP3 STARD9 TNXB MARCKS	3.50e-07	191	154	8	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 CYP1B1 NFASC ZFPM2 MYOF THBS1 NFATC2 KIAA1755	4.43e-07	197	154	8	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.43e-07	197	154	8	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 CYP1B1 NFASC ZFPM2 MYOF THBS1 NFATC2 KIAA1755	4.43e-07	197	154	8	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	Ciliated_cells-A-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 DNAJB13 CFAP74 TTLL10 FOXJ1	3.04e-06	179	154	7	0e6c22de2e3fb0ff23b3301863cf4011c5c59dff
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	GTF2IRD1 HIVEP3 MYOF NRK MACROD2 ULK2 RAI1	3.40e-06	182	154	7	a8cc56f32efe180e8fb5d69dbe606a794b3db700
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	3.78e-06	185	154	7	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.06e-06	187	154	7	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.36e-06	189	154	7	dc440015949a768188c67661b6be63b1ead1a0f0
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYP1B1 MYOF THBS1 GJB3 HOXB9 KIAA1755 FOXJ1	4.51e-06	190	154	7	050d6e0546954675b6adbfecb67854b1e09739d1
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	4.51e-06	190	154	7	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MAP1A CCDC146 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.51e-06	190	154	7	a90a38fccdbf75a286b4d258fc54920c02b282f7
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CDH23 PCDH12 ITGA9 SHANK3 AHNAK TNXB MARCKS	5.00e-06	193	154	7	daefbfd3a3dd1351fbe94b9abfd807db44d56c24
ToppCell	LAM-Epithelial-AirwayEpi\|Epithelial / Condition, Lineage and Cell class	MAP1A CCDC146 EFHB DNAJB13 TTLL10 MARCKS FOXJ1	5.00e-06	193	154	7	f2672d2c495ee12c3b7d132452bde581fa5a7856
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.17e-06	194	154	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 GGA2 HIP1R PDLIM1 AHNAK MACROD2 MARCKS	5.35e-06	195	154	7	481989d2e5bd2582da3d86b0155c4d6615317067
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 GGA2 HIP1R PDLIM1 AHNAK MACROD2 MARCKS	5.35e-06	195	154	7	6108a27523d1b93a7fbe35cb95704a5ad9071e3c
ToppCell	distal-Epithelial-Proximal_Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CCDC146 FRMPD2 EFHB DNAJB13 CRACD CFAP74 FOXJ1	5.35e-06	195	154	7	abe7998421dc59bdae35c0c2251c4a1ebef5e021
ToppCell	facs-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SRSF1 STRBP GTF2IRD1 FKBP5 MARCKS CUX1 CDK2	5.35e-06	195	154	7	79114b3c78cc15c413bb58f0673e7215b784a9b6
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.35e-06	195	154	7	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	distal-Epithelial-Proximal_Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CCDC146 FRMPD2 EFHB DNAJB13 CRACD CFAP74 FOXJ1	5.35e-06	195	154	7	0e3f74e0877d33c11f048b9be8394596cf5c9c4c
ToppCell	moderate-Epithelial-Ciliated\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.35e-06	195	154	7	e80f5cdf0b18066b3e6c2f5452e58f101c67932c
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	5.53e-06	196	154	7	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	control-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	5.72e-06	197	154	7	e453d085182364ca347cbcc9dc995c62c3353016
ToppCell	control-Epithelial-Ciliated\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	5.72e-06	197	154	7	d4e963c1f82996371bf3d63578ee9fce8e00c5a8
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	MAP1A CCDC146 FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	5.91e-06	198	154	7	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	COL4A2 CYP1B1 HIVEP3 MYOF THBS1 LMAN1 HSPA5	6.11e-06	199	154	7	fde2b65afde69f402f1b7b056eaa266e9fd5b227
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	6.31e-06	200	154	7	ddd39b754bfaa98249d497dfb7e97ec58617a11a
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Ciliated\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	6.31e-06	200	154	7	a521cf837cadf280505ff9d7e641a205af7d6513
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CCDC146 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	6.31e-06	200	154	7	918b576fd9491d23c2bb9d663fa5fb3505cb1c7e
ToppCell	15-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	SOX30 FRMPD2 EFHB DNAJB13 CFAP74 TTLL10	2.73e-05	169	154	6	425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCell	Endothelial-B-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	NFASC PCDH12 SHANK3 FAM171A1 TNXB MARCKS	3.01e-05	172	154	6	d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell	Endothelial-B-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	COL4A2 VIP PCDH12 ZFPM2 ADAMTS7 TNXB	3.01e-05	172	154	6	8a527dff06d841a86c7eb04a1dd9630787294da4
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	BDP1 GGA2 HIP1R PDLIM1 AHNAK MARCKS	3.11e-05	173	154	6	d56e337eae727a29cd53cfd628e1b3c0a98e1f51
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 MAP1A ZFPM2 THBS1 PDLIM1 NFATC2	3.31e-05	175	154	6	910a075ccaf79de22338ecf321fa0a867f3d7d75
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CDH23 NFASC ITGA9 ZFPM2 KIAA1755 TNXB	3.31e-05	175	154	6	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A2 MAP1A ZFPM2 THBS1 PDLIM1 NFATC2	3.31e-05	175	154	6	f0c2eb82e17e8aec2cfa5d83169178f409cc1abc
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PCDH12 ITGA9 THBS1 FCGBP SCPEP1 FKBP5	3.53e-05	177	154	6	382f0d6bbff01e84b0c7840e74ac865864e6da89
ToppCell	Ciliated_cells-B-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	CCDC146 FRMPD2 EFHB MYLK3 TTLL10 FOXJ1	3.53e-05	177	154	6	c38138fb5ad9766c2d240811210c854338cd612e
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A FRMPD2 TUB DNAJB13 TTLL10 FOXJ1	3.65e-05	178	154	6	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 TTBK2 ARNT SH3TC1 NIM1K TNXB	3.76e-05	179	154	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	C2CD2 ZFPM2 ADAMTS7 NRK NINL KIAA1755	3.76e-05	179	154	6	ce3ca7f3a5864e62307aa744a3173f350a90df28
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	COL4A2 VIP SHANK3 PDLIM1 STARD9 NRK	4.13e-05	182	154	6	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL4A2 IRS1 TACC2 ZFPM2 THBS1 NFATC2	4.13e-05	182	154	6	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	Ciliated_cells-B-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	CCDC146 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.52e-05	185	154	6	4fc7113d3dadc716ec5a8e62b58543cc00ce5b16
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A FRMPD2 EFHB DNAJB13 CFAP74 TTLL10	4.52e-05	185	154	6	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	CCDC146 FRMPD2 DNAJB13 CFAP74 TTLL10 FOXJ1	4.52e-05	185	154	6	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	droplet-Lung-LUNG-1m-Epithelial-Club_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 NFASC FAM83H RPP25 CRACD PARD3	4.66e-05	186	154	6	e52cf44989c57c433bf82e9fa13b4643e88f3577
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	CCDC146 FRMPD2 DNAJB13 CFAP74 TTLL10 FOXJ1	4.66e-05	186	154	6	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac\|normal_Pleural_Fluid / Location, Cell class and cell subclass	CYP1B1 MAP1A ITGA9 GTF2IRD1 THBS1 CDK5	4.66e-05	186	154	6	3314def702fe6a5056d0dadbb3a587c5d1a16412
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MAP1A FRMPD2 EFHB CFAP74 TTLL10 FOXJ1	4.66e-05	186	154	6	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	droplet-Lung-LUNG-1m-Epithelial-club_cell_of_bronchiole\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 NFASC FAM83H RPP25 CRACD PARD3	4.66e-05	186	154	6	4c0b59d845b79323e7a3287e7c4d249f5f322556
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 PCDH12 SHANK3 ZFPM2 FAM171A1 CDK13	4.66e-05	186	154	6	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 PCDH12 SHANK3 ZFPM2 FAM171A1 CDK13	4.66e-05	186	154	6	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	4.66e-05	186	154	6	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EPS8L2 HIP1R CRACD FCGBP GPR158 MACROD2	4.66e-05	186	154	6	bb0bfe9a015151be08a6ffc5d82896d0556d76de
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 DNAJB13 CFAP74 TTLL10 FOXJ1	4.80e-05	187	154	6	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 FAM83H RPP25 GJB3 HOXB9 POLI	4.80e-05	187	154	6	22fd1959879705a8c1128faa9de66696c4e0b7e3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INPP5D PCDH12 ITGA9 SHANK3 STARD9 TNXB	4.80e-05	187	154	6	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 FAM83H RPP25 GJB3 HOXB9 POLI	4.80e-05	187	154	6	5fae538de481367cf6d9a2d52190d77b99f6922c
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 FAM83H RPP25 GJB3 HOXB9 POLI	4.80e-05	187	154	6	0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	MAP1A CCDC146 FRMPD2 CFAP74 TTLL10 FOXJ1	4.94e-05	188	154	6	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7\|TCGA-Colorectal / Sample_Type by Project: Shred V9	COL4A2 DIDO1 ANKRD27 SETDB2 KIF3B KIAA1755	4.94e-05	188	154	6	14bc73cf79c79c9f208369fd8d498e5b26e0114d
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IQSEC3 ITGA9 ZFPM2 ADAMTS7 TNXB MARCKS	4.94e-05	188	154	6	26915db8863f4115b46a81982e187322e21600fd
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EPS8L2 GTF2IRD1 NEDD9 MYOF NRK PARD3	4.94e-05	188	154	6	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IQSEC3 ITGA9 ZFPM2 ADAMTS7 TNXB MARCKS	4.94e-05	188	154	6	3f76c0f912f8f023ea425be7f43593b3d7f967e3
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 EFHB TTLL10 FOXJ1	4.94e-05	188	154	6	606907c865bd2f11bb6474932716550f7723d858
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IQSEC3 ITGA9 ZFPM2 ADAMTS7 TNXB MARCKS	4.94e-05	188	154	6	61ee7b152745164293d8a44ef91ee2393efbdca5
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GGA2 RASGRF1 STRBP HIP1R PDLIM1 MARCKS	4.94e-05	188	154	6	6f53bcd4caab2fc961af799039ea5c3ddae56781
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CCDC146 FRMPD2 DNAJB13 CFAP74 TTLL10 FOXJ1	4.94e-05	188	154	6	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.09e-05	189	154	6	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MAP1A CCDC146 EFHB KIF3B TTLL10 FOXJ1	5.09e-05	189	154	6	b4b93bd10b7e3cc16e54ff73beac230f519c010a
ToppCell	Multiciliated\|World / shred by cell class for nasal brushing	MAP1A CCDC146 FRMPD2 CFAP74 TTLL10 FOXJ1	5.09e-05	189	154	6	34b110aef839376228c5a403a6b5047a945f472b
ToppCell	Ciliated\|World / shred by cell class for parenchyma	CCDC146 FRMPD2 DNAJB13 CFAP74 TTLL10 FOXJ1	5.09e-05	189	154	6	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.09e-05	189	154	6	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	MAP1A CCDC146 FRMPD2 EFHB TTLL10 FOXJ1	5.24e-05	190	154	6	9ce7df056bfb24d70db4c3c4a2c57d89115de877
ToppCell	Epithelial_cells-Ciliated_cells-A\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 CFAP74 TTLL10 MARCKS FOXJ1	5.24e-05	190	154	6	549d813a8f23b175875e53347928941f143e236c
ToppCell	Nasal_Brush-Epithelial-Ciliated_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	MAP1A CCDC146 FRMPD2 EFHB TTLL10 FOXJ1	5.24e-05	190	154	6	833481ace2800354712e2ce709d5cdfd0aed3d42
ToppCell	COVID_vent-Lymphocytic-B_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GGA2 STRBP HIP1R PDLIM1 MACROD2 MARCKS	5.24e-05	190	154	6	40b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCell	COVID_vent-Lymphocytic-B_cell-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	GGA2 STRBP HIP1R PDLIM1 MACROD2 MARCKS	5.24e-05	190	154	6	a37a32dc1b931562a6660074e19d5598efc65284
ToppCell	Ciliated_cells-A\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A CCDC146 FRMPD2 CFAP74 TTLL10 FOXJ1	5.24e-05	190	154	6	cd87731aaa7d252424f79cfce9f7931457f17bdf
ToppCell	ILEUM-non-inflamed-(8)_Activated_fibroblasts\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAP1A NOL6 PALB2 KIAA1755 MMP3 PARD3	5.24e-05	190	154	6	39fa110d19c97c7cac99f5fb91b26bc08e2f3b42
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.40e-05	191	154	6	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.40e-05	191	154	6	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MAP1A CCDC146 FRMPD2 TTLL10 MARCKS FOXJ1	5.40e-05	191	154	6	dad675251e129254955eac179c84a641a4864586
ToppCell	356C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MAP1A CCDC146 FRMPD2 TTLL10 MARCKS FOXJ1	5.40e-05	191	154	6	6d2cf41ee946137c039ddcc13593fc3f670afbba
ToppCell	(2)_Fibroblasts-(21)_Fibro-2\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	CYP1B1 RASGRF1 CDH23 PDLIM1 TNXB CUX1	5.40e-05	191	154	6	5ee353c79055c08e8a3e2b43a0345bceb09f3890
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.40e-05	191	154	6	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.40e-05	191	154	6	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	FRMPD2 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.40e-05	191	154	6	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	droplet-Spleen-SPLEEN-1m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GGA2 STRBP HIP1R HNRNPK NEDD9 EEF2	5.55e-05	192	154	6	9b8191e66626919cad2c63349c8ef61e9792fcf5
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	COL4A2 NFASC PCDH12 SHANK3 ZFPM2 ALPK3	5.55e-05	192	154	6	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CYP1B1 NFASC ITGA9 ZFPM2 CRACD TNXB	5.55e-05	192	154	6	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	normal_Lung-Epithelial_cells-Ciliated\|normal_Lung / Location, Cell class and cell subclass	CCDC146 EFHB DNAJB13 CFAP74 TTLL10 FOXJ1	5.55e-05	192	154	6	097a13121820ab4e5cd2365600efccf5ea4ce8c3
ToppCell	human_hepatoblastoma-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	BDP1 DAP NEDD9 UBR5 MACROD2 MARCKS	5.55e-05	192	154	6	916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell	Bronchial_Biopsy-Epithelial-Ciliated_1\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	MAP1A CCDC146 FRMPD2 EFHB TTLL10 FOXJ1	5.55e-05	192	154	6	be592e661367affced9ebe80849b466e6adb3a34
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A2 ITGA9 MYOF THBS1 AHNAK TNXB	5.55e-05	192	154	6	a42aed9e563f5f4af029b8804c104f11ad227a8f
ToppCell	multiciliated\|World / shred by cell class for turbinate	MAP1A CCDC146 FRMPD2 DNAJB13 TTLL10 FOXJ1	5.55e-05	192	154	6	0f89ea0deb651ca11531c51ee94e0233608d22ea
Drug	Mebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A	CYP1B1 TBC1D9B MAP1A BAZ2B NOL6 AGPAT2 MAGEF1 RPP25 MYOF EHBP1L1 MAP1S	9.70e-08	198	152	11	7370_DN
Drug	dimethyloxalylglycine; Down 200; 1000uM; PC3; HG-U133A	CYP1B1 SRSF1 FXR2 DIDO1 PALB2 DNAAF2 THBS1 ARNT SNAPC4 EN2	8.26e-07	196	152	10	584_DN
Drug	Chlorpromazine hydrochloride [69-09-0]; Up 200; 11.2uM; HL60; HT_HG-U133A	TBC1D9B GTF2IRD1 PLA2G15 RPP25 NEDD9 KIF3B TMCC1 FKBP5 CUX1	6.20e-06	193	152	9	1864_UP
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A	CYP1B1 NPR2 GGA2 SRSF1 CAPN10 MYOF THBS1 MAP1S CABIN1	6.20e-06	193	152	9	5758_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A	TBC1D9B GGA2 PLA2G15 RPP25 THBS1 LMAN1 CDK13 EN2 TMCC1	7.02e-06	196	152	9	4645_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; PC3; HT_HG-U133A	MAP1A FXR2 BAZ2B AGPAT2 NEDD9 SCPEP1 PARD3 CABIN1 TMCC1	7.62e-06	198	152	9	6304_DN
Drug	Chlorhexidine [55-56-1]; Down 200; 8uM; MCF7; HT_HG-U133A	CHML MAGEF1 CAPN10 MYOF ARNT EHBP1L1 MAP1S SNAPC4 TMCC1	7.62e-06	198	152	9	1525_DN
Drug	Methacholine chloride [62-51-1]; Down 200; 20.4uM; PC3; HT_HG-U133A	PLA2G15 MAGEF1 MSX2 MYOF HTATSF1 ARHGEF2 CABIN1 ULK2 TMCC1	7.94e-06	199	152	9	5773_DN
Drug	melatonin	CACNA1B VIP CYP1B1 FXR2 NOL6 IRS1 HNRNPK EEF2 ARNT SCPEP1 FOXG1 RAI1 CDK5	9.09e-06	443	152	13	CID000000896
Drug	F0447-0125; Down 200; 10uM; PC3; HT_HG-U133A	CYP1B1 C1RL MYOF GJB3 AHNAK POLI TMCC1 HDLBP	3.40e-05	184	152	8	6429_DN
Drug	Rescinnamin [24815-24-5]; Up 200; 6.4uM; HL60; HT_HG-U133A	CYP1B1 SRSF1 INPP5D RPP25 MYOF THBS1 FOXG1 CUX1	3.67e-05	186	152	8	2130_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	CYP1B1 GGA2 AGPAT2 PALB2 RPP25 SNAPC4 FKBP5 CDK5	4.12e-05	189	152	8	5203_DN
Drug	Acacetin [480-44-4]; Down 200; 14uM; HL60; HT_HG-U133A	CYP1B1 DIDO1 GTF2IRD1 PLA2G15 CAPN10 HIVEP3 MYOF ARNT	4.27e-05	190	152	8	2189_DN
Drug	CP-944629 [668990-94-1]; Down 200; 10uM; PC3; HT_HG-U133A	CYP1B1 TBC1D9B MAGEF1 THBS1 LMAN1 FUBP1 ARHGEF2 CDK2	4.43e-05	191	152	8	7549_DN
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; HL60; HT_HG-U133A	GGA2 SRSF1 PLA2G15 LMAN1 CDK13 ATM ARHGEF2 CDK2	4.43e-05	191	152	8	6142_DN
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	DCAF15 SRSF1 FXR2 NEDD9 MYOF UBR5 AHNAK ATM	4.43e-05	191	152	8	4168_DN
Drug	Megestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A	GGA2 HIVEP3 THBS1 GJB3 LMAN1 CDK13 MMP3 FKBP5	4.60e-05	192	152	8	5013_UP
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	CYP1B1 HIP1R PLA2G15 PALB2 DNAAF2 NARF TMCC1 MARCKS	4.77e-05	193	152	8	6985_DN
Drug	PHA-00851261E [724719-49-7]; Up 200; 1uM; MCF7; HT_HG-U133A	COL4A2 CYP1B1 GGA2 HIVEP3 THBS1 HOXB9 LMAN1 HTATSF1	4.77e-05	193	152	8	3857_UP
Drug	Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A	COL4A2 CYP1B1 TBC1D9B GGA2 AGPAT2 MYOF ARNT EHBP1L1	4.77e-05	193	152	8	6646_DN
Drug	Metformin hydrochloride [1115-70-4]; Up 200; 24.2uM; PC3; HT_HG-U133A	GGA2 ZNF236 HIVEP3 ARNT LMAN1 SH3TC1 ATM MMP3	4.77e-05	193	152	8	1816_UP
Drug	Nifurtimox [23256-30-6]; Down 200; 14uM; MCF7; HT_HG-U133A	DCAF15 GGA2 SRSF1 CHML LMAN1 CDK13 FKBP5 CDK2	4.95e-05	194	152	8	4953_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; HL60; HT_HG-U133A	RSF1 GTF2IRD1 CAPN10 TTBK2 THBS1 LMAN1 HTATSF1 CABIN1	5.13e-05	195	152	8	1866_DN
Drug	Tiletamine hydrochloride; Down 200; 15.4uM; HL60; HT_HG-U133A	COL4A2 MYOF CDK13 SNAPC4 PARD3 ULK2 TMCC1 HDLBP	5.13e-05	195	152	8	3137_DN
Drug	leukotoxin B (12,13-EODE); Up 200; 0.2uM; MCF7; HT_HG-U133A_EA	CYP1B1 TACC2 CHML NEDD9 ATM ARHGEF2 CABIN1 HDLBP	5.13e-05	195	152	8	1108_UP
Drug	Cisapride [81098-60-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	DCAF15 GGA2 SRSF1 AGPAT2 C1RL THBS1 ULK2 FKBP5	5.13e-05	195	152	8	6706_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	FXR2 GJB3 EHBP1L1 LMAN1 MAP1S ARHGEF2 CABIN1 TMCC1	5.13e-05	195	152	8	6268_UP
Drug	Telenzepine dihydrochloride [147416-96-4]; Down 200; 9uM; MCF7; HT_HG-U133A	DCAF15 FAM193B NPR2 FXR2 DAP NEDD9 NINL CABIN1	5.32e-05	196	152	8	7419_DN
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A	CYP1B1 PCDH12 CAPN10 THBS1 HOXB9 CABIN1 FOXG1 HDLBP	5.32e-05	196	152	8	4208_DN
Drug	Retinoic acid [302-79-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	DCAF15 BAZ2B C1RL NEDD9 MSX2 EHBP1L1 CABIN1 TMCC1	5.32e-05	196	152	8	5767_DN
Drug	Meclofenamic acid sodium salt monohydrate [6385-02-0]; Down 200; 11.8uM; PC3; HT_HG-U133A	AGPAT2 CAPN10 NEDD9 MSX2 ARNT LMAN1 CDK13 MARCKS	5.52e-05	197	152	8	2128_DN
Drug	Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; PC3; HT_HG-U133A	CYP1B1 TBC1D9B GGA2 PCDH12 NEDD9 LMAN1 CABIN1 FKBP5	5.52e-05	197	152	8	4207_DN
Drug	Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; HL60; HG-U133A	BAZ2B NOL6 DIDO1 MAGEF1 TTBK2 MYOF UBR5 ZNF264	5.52e-05	197	152	8	1747_DN
Drug	Reserpinic acid hydrochloride; Down 200; 9.2uM; HL60; HT_HG-U133A	HIP1R PCDH12 MAGEF1 THBS1 PDLIM1 CDK13 AHNAK TMCC1	5.52e-05	197	152	8	2903_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Up 200; 16.4uM; HL60; HT_HG-U133A	EPS8L2 HIP1R MSX2 MYOF GJB3 SH3TC1 ADAMTS7 FOXG1	5.52e-05	197	152	8	2463_UP
Drug	Dimenhydrinate [523-87-5]; Down 200; 8.6uM; PC3; HT_HG-U133A	GGA2 CAPN10 GJB3 HOXB9 EHBP1L1 LMAN1 SCPEP1 TMCC1	5.72e-05	198	152	8	6352_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A	NEDD9 TTBK2 GJB3 ARNT EHBP1L1 SNAPC4 PARD3 FOXG1	5.72e-05	198	152	8	5582_DN
Drug	Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A	CYP1B1 NPR2 TBC1D9B GGA2 DIDO1 TACC2 ARNT ZNF264	5.72e-05	198	152	8	4090_DN
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	FAM193B GGA2 FXR2 AGPAT2 MAGEF1 AHNAK SNAPC4 FOXG1	5.72e-05	198	152	8	1244_DN
Drug	Imipenem [74431-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A	CYP1B1 NPR2 BAZ2B HIP1R CAPN10 RPP25 MAP1S PARD3	5.72e-05	198	152	8	7294_DN
Drug	D-cycloserine [68-41-7]; Up 200; 39.2uM; PC3; HT_HG-U133A	FAM193B GGA2 ZFPM2 THBS1 MAP1S SH3TC1 ARHGEF2 ULK2	5.92e-05	199	152	8	7134_UP
Drug	Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A	GGA2 MAP1A FXR2 DIDO1 CHML PLA2G15 MAGEF1 ULK2	5.92e-05	199	152	8	2083_DN
Drug	Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A	COL4A2 DCAF15 GGA2 CAPN10 SH3TC1 CDK13 ATM CABIN1	6.14e-05	200	152	8	2077_UP
Drug	AC1NB8R3	FXR2 RSF1 HNRNPK SCPEP1 ATM EN2 FOXG1 RAI1	9.52e-05	213	152	8	CID004489307
Drug	deoxythymidin	VIP FXR2 IRS1 HNRNPK NRK POLI SCPEP1 ATM CDK2	1.03e-04	276	152	9	CID000001134
Drug	NSC105327	CYP1B1 ARNT CDK13 CDK2 CDK5	1.06e-04	70	152	5	CID005318433
Drug	isocycloheximide	CYP1B1 ALLC NOL6 IRS1 NEDD9 THBS1 EEF2 GJB3 ARNT MYLK3 CDK13 NRK MMP3 HSPA5 FKBP5 CUX1 CDK2	1.19e-04	905	152	17	CID000002900
Drug	1-ethynylpyrene	CYP1B1 ARNT	1.32e-04	3	152	2	ctd:C042881
Drug	Hymenialdisine	CDK2 CDK5	1.32e-04	3	152	2	DB02950
Drug	CDK1 inhibitor III	CDK2 CDK5	1.32e-04	3	152	2	CID000403994
Drug	SU9516	CDK2 CDK5	1.32e-04	3	152	2	DB03428
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CYP1B1 DIDO1 IRS1 TACC2 GTF2IRD1 THBS1 CDK13	1.60e-04	172	152	7	1072_DN
Drug	3,3',4,5'-tetrahydroxystilbene	CYP1B1 IRS1 ARNT ATM CDK2	2.11e-04	81	152	5	ctd:C041525
Drug	potassium hydride	FXR2 HNRNPK SCPEP1 STAG2 MARCKS HDLBP	2.23e-04	128	152	6	CID000082127
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A	CYP1B1 SRSF1 CHML NEDD9 LMAN1 ATM FOXG1	2.27e-04	182	152	7	4376_DN
Drug	AC1L1IS7	CAPN10 EEF2 HSPA5 CDK5	2.30e-04	45	152	4	CID000004711
Drug	AC1L1DW2	CACNA1B IRS1 CAPN10 NRK CABIN1 CUX1 CDK5	2.59e-04	186	152	7	CID000002532
Drug	0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A	PALB2 NEDD9 DNAAF2 GJB3 MAP1S PARD3 TMCC1	2.59e-04	186	152	7	6875_DN
Drug	Alsterpaullone	CDK2 CDK5	2.63e-04	4	152	2	DB04014
Drug	Olomoucine	CDK2 CDK5	2.63e-04	4	152	2	DB02116
Drug	Indirubin-3'-Monoxime	CDK2 CDK5	2.63e-04	4	152	2	DB02052
Drug	0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A	DCAF15 NEDD9 GJB3 SH3TC1 ATM PARD3 HDLBP	2.68e-04	187	152	7	6902_UP
Drug	Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A	COL4A2 RSF1 DIDO1 C1RL CAPN10 ARNT ALPK3	2.68e-04	187	152	7	1242_UP
Drug	Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A	CYP1B1 GGA2 C2CD2 NEDD9 MYOF CDK13 MARCKS	2.85e-04	189	152	7	4401_DN
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA	SRSF1 NOL6 C2CD2 RPP25 MSX2 THBS1 UBR5	2.85e-04	189	152	7	1065_DN
Drug	Ketoconazole [65277-42-1]; Up 200; 7.6uM; HL60; HT_HG-U133A	COL4A2 SRSF1 MAGEF1 CAPN10 THBS1 SH3TC1 TMCC1	2.85e-04	189	152	7	1285_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; PC3; HT_HG-U133A	GGA2 NOL6 AGPAT2 SH3TC1 ZNF264 ATM SNAPC4	2.95e-04	190	152	7	4582_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	CYP1B1 FAM193B DNAAF2 EHBP1L1 SNAPC4 ULK2 MARCKS	2.95e-04	190	152	7	836_DN
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A	DCAF15 GGA2 SRSF1 THBS1 LMAN1 CDK13 SNAPC4	2.95e-04	190	152	7	6718_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A	GGA2 SRSF1 MSX2 THBS1 AHNAK ATM CDK2	2.95e-04	190	152	7	1636_DN
Drug	vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A	DCAF15 TBC1D9B GGA2 RPP25 ARNT SNAPC4 CABIN1	3.14e-04	192	152	7	7556_UP
Drug	Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	COL4A2 CYP1B1 DCAF15 C1RL CHML MYOF GJB3	3.14e-04	192	152	7	3460_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	COL4A2 NPR2 NOL6 ZNF236 CHML HIVEP3 CABIN1	3.14e-04	192	152	7	2450_DN
Drug	0317956-0000 [391210-11-0]; Up 200; 1uM; MCF7; HT_HG-U133A	GGA2 PCDH12 THBS1 ARNT CDK13 HTATSF1 ULK2	3.14e-04	192	152	7	3858_UP
Drug	PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A	CYP1B1 DCAF15 GGA2 SRSF1 DNAAF2 MSX2 THBS1	3.14e-04	192	152	7	4288_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A	CYP1B1 GGA2 CFAP74 ATM PARD3 CDK5 HDLBP	3.14e-04	192	152	7	1623_DN
Drug	0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A	CYP1B1 NPR2 ZNF236 MYOF CDK13 HTATSF1 MMP3	3.24e-04	193	152	7	3693_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	PCDH12 THBS1 ARNT PDLIM1 PARD3 TMCC1 CUX1	3.24e-04	193	152	7	1183_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	GGA2 SRSF1 MAGEF1 MYOF HTATSF1 ZNF264 ATM	3.24e-04	193	152	7	3667_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A	SRSF1 CHML C2CD2 MAGEF1 HTATSF1 ATM FKBP5	3.24e-04	193	152	7	2294_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; MCF7; HT_HG-U133A	CYP1B1 NEDD9 THBS1 EHBP1L1 SNAPC4 PARD3 CABIN1	3.24e-04	193	152	7	5608_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; PC3; HT_HG-U133A	CYP1B1 MAGEF1 MSX2 THBS1 ARNT LMAN1 CDK2	3.24e-04	193	152	7	4623_DN
Drug	Iohexol [66108-95-0]; Down 200; 4.8uM; MCF7; HT_HG-U133A	GGA2 HIVEP3 ARNT LMAN1 MMP3 ARHGEF2 FKBP5	3.24e-04	193	152	7	3322_DN
Drug	Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; HL60; HT_HG-U133A	COL4A2 ZNF236 MAGEF1 CAPN10 LMAN1 HTATSF1 FKBP5	3.24e-04	193	152	7	3098_DN
Drug	Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A	GGA2 SRSF1 ANKRD27 MYOF GJB3 SH3TC1 PARD3	3.34e-04	194	152	7	4838_UP
Drug	Etodolac [41340-25-4]; Down 200; 14uM; PC3; HT_HG-U133A	GGA2 SRSF1 AGPAT2 PLA2G15 CAPN10 MYOF LMAN1	3.34e-04	194	152	7	2091_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SRSF1 IRS1 MYOF THBS1 STAG2 MARCKS CDK2	3.34e-04	194	152	7	5017_DN
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A	COL4A2 GGA2 AGPAT2 GTF2IRD1 LMAN1 PARD3 FOXG1	3.34e-04	194	152	7	2434_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A	SRSF1 FXR2 PCDH12 CAPN10 NEDD9 CABIN1 TMCC1	3.34e-04	194	152	7	6778_DN
Drug	Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A	DCAF15 SRSF1 MAP1A DNAAF2 CABIN1 EN2 ULK2	3.34e-04	194	152	7	4325_DN
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	SRSF1 SOX30 ZNF236 CHML MMP3 ARHGEF2 EN2	3.45e-04	195	152	7	4814_UP
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	CYP1B1 SRSF1 MYOF ARNT LMAN1 FKBP5 FOXG1	3.45e-04	195	152	7	3812_DN
Drug	H-89, Dihydrochloride; Down 200; 0.5uM; PC3; HT_HG-U133A	SRSF1 AGPAT2 PCDH12 LMAN1 ATM CABIN1 CDK2	3.45e-04	195	152	7	6921_DN
Drug	Rimexolone [49697-38-3]; Down 200; 10.8uM; PC3; HT_HG-U133A	CYP1B1 BAZ2B AGPAT2 HIP1R CHML PLA2G15 CDK2	3.45e-04	195	152	7	5092_DN
Drug	Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A	TBC1D9B GGA2 FXR2 AGPAT2 HIP1R MAGEF1 FUBP1	3.45e-04	195	152	7	1207_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	NPR2 HIVEP3 THBS1 GJB3 EHBP1L1 LMAN1 FKBP5	3.45e-04	195	152	7	3315_DN
Drug	5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	GGA2 MAP1A PCDH12 CAPN10 NEDD9 EHBP1L1 ARHGEF2	3.45e-04	195	152	7	920_UP
Drug	Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A	NOL6 MAGEF1 CAPN10 NEDD9 MYOF ARNT GCC1	3.45e-04	195	152	7	1162_DN
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	CYP1B1 GGA2 MAGEF1 TTBK2 THBS1 ARNT ATM	3.45e-04	195	152	7	6522_DN
Drug	Erythromycin [114-07-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	DCAF15 NPR2 GGA2 NEDD9 SNAPC4 CABIN1 TMCC1	3.45e-04	195	152	7	5329_DN
Disease	infection	INPP5D RSF1 MACROD2	1.06e-05	9	150	3	EFO_0000544
Disease	lung non-small cell carcinoma (is_marker_for)	SRSF1 SOX30 ITGA9 EEF2 UBR5 ATM CUX1	2.64e-05	169	150	7	DOID:3908 (is_marker_for)
Disease	stomach cancer (is_marker_for)	SRSF1 EEF2 UBR5 FUBP1 ATM CUX1	9.05e-05	142	150	6	DOID:10534 (is_marker_for)
Disease	Intellectual Disability	CACNA1B VIP IQSEC3 PCDH12 SHANK3 HNRNPK CAPN10 STAG2 FOXG1 RAI1	1.02e-04	447	150	10	C3714756
Disease	Malignant neoplasm of breast	CYP1B1 TBC1D9B SRSF1 STRBP RPS7 TACC2 ITGA9 PALB2 HNRNPK THBS1 EEF2 HOXB9 ATM MMP3 CUX1 HDLBP	1.21e-04	1074	150	16	C0006142
Disease	pancreatic cancer (is_implicated_in)	ITGA9 PALB2 CAPN10 THBS1 ATM	2.75e-04	112	150	5	DOID:1793 (is_implicated_in)
Disease	melanoma	CYP1B1 ARNT ATM STAG2 CUX1 RAI1 CDK2	2.89e-04	248	150	7	C0025202
Disease	JT interval	DRGX ZFPM2 ARNT CDK13 ALPK3 CUX1 RAI1	2.89e-04	248	150	7	EFO_0007885
Disease	sh2 domain-containing protein 1a measurement	RPS7 STAG2	3.80e-04	6	150	2	EFO_0020737
Disease	childhood onset asthma, age at onset, environmental tobacco smoke exposure measurement	CYP1B1 MACROD2	3.80e-04	6	150	2	EFO_0004847, EFO_0008361, MONDO_0005405
Disease	coronary artery disease	COL4A2 CYP1B1 VPS11 INPP5D RPS7 TUB ZFPM2 NEDD9 CRACD EHBP1L1 MAP1S ADAMTS7 CABIN1 TNXB FKBP5 RAI1	3.96e-04	1194	150	16	EFO_0001645
Disease	level of oxylipin in blood plasma	ITGA9 KIAA1755	5.30e-04	7	150	2	OBA_2050338
Disease	Large cell carcinoma of lung	NIM1K ALPK3 BRSK1	5.73e-04	32	150	3	C0345958
Disease	Schizophrenia	CACNA1B VIP SRSF1 NFASC SHANK3 THBS1 CACNG8 ATM MMP3 EN2 TNXB RAI1 CDK5	5.98e-04	883	150	13	C0036341
Disease	female breast cancer (is_implicated_in)	PALB2 ATM	7.04e-04	8	150	2	DOID:0050671 (is_implicated_in)
Disease	Profound Mental Retardation	VIP SHANK3 CAPN10 FOXG1 RAI1	7.39e-04	139	150	5	C0020796
Disease	Mental Retardation, Psychosocial	VIP SHANK3 CAPN10 FOXG1 RAI1	7.39e-04	139	150	5	C0025363
Disease	Mental deficiency	VIP SHANK3 CAPN10 FOXG1 RAI1	7.39e-04	139	150	5	C0917816
Disease	Bipolar Disorder	CACNA1B VIP RASGRF1 HIP1R ITGA9 PALB2 STARD9 HSPA5 FKBP5	7.78e-04	477	150	9	C0005586
Disease	Nonsyndromic Deafness	BDP1 EPS8L2 CDH23 GJB3	7.88e-04	81	150	4	C3711374
Disease	lung squamous cell carcinoma (is_marker_for)	SRSF1 SOX30 FUBP1	8.13e-04	36	150	3	DOID:3907 (is_marker_for)
Disease	lung adenocarcinoma (is_marker_for)	SRSF1 SOX30 EEF2 FUBP1	9.44e-04	85	150	4	DOID:3910 (is_marker_for)
Disease	guanosine diphosphate measurement	BAZ2B NINL	1.37e-03	11	150	2	EFO_0010494
Disease	Adenocarcinoma of large intestine	UBR5 NRK ATM CUX1	1.48e-03	96	150	4	C1319315
Disease	basophil count, eosinophil count	INPP5D DAP HIVEP3 NFATC2 ATM TNXB	1.50e-03	241	150	6	EFO_0004842, EFO_0005090
Disease	Mammary Carcinoma, Human	CYP1B1 RPS7 PALB2 HNRNPK THBS1 EEF2 HOXB9 ATM MMP3	1.51e-03	525	150	9	C4704874
Disease	Mammary Neoplasms, Human	CYP1B1 RPS7 PALB2 HNRNPK THBS1 EEF2 HOXB9 ATM MMP3	1.51e-03	525	150	9	C1257931
Disease	Mammary Neoplasms	CYP1B1 RPS7 PALB2 HNRNPK THBS1 EEF2 HOXB9 ATM MMP3	1.55e-03	527	150	9	C1458155
Disease	Neurobehavioral Manifestations	FKBP5 RAI1	1.64e-03	12	150	2	C0525041
Disease	Primary Ciliary Dyskinesia	DNAJB13 DNAAF2 FOXJ1	1.77e-03	47	150	3	C4551720
Disease	Breast Carcinoma	CYP1B1 RPS7 PALB2 HNRNPK THBS1 EEF2 HOXB9 ATM MMP3	1.79e-03	538	150	9	C0678222
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	CDH23 GJB3	1.93e-03	13	150	2	C1846647
Disease	C-X-C motif chemokine 11 measurement	ZFPM2 CUX1	2.24e-03	14	150	2	EFO_0008057
Disease	serum gamma-glutamyl transferase measurement	MAP1A RPS7 ITGA9 MAP1S AHNAK ZFP91 MACROD2 ARHGEF2 PARD3 CABIN1 FKBP5 HDLBP	2.53e-03	914	150	12	EFO_0004532
Disease	Neoplasm of uncertain or unknown behavior of bladder	ATM STAG2	2.58e-03	15	150	2	C0496930
Disease	Benign neoplasm of bladder	ATM STAG2	2.58e-03	15	150	2	C0154017
Disease	Carcinoma in situ of bladder	ATM STAG2	2.58e-03	15	150	2	C0154091
Disease	Peripheral Nervous System Diseases	CACNA1B GJB3 MMP3	2.64e-03	54	150	3	C4721453
Disease	Metastatic melanoma	ALPK3 BRSK1 ULK2	2.64e-03	54	150	3	C0278883
Disease	cystatin-F measurement	ZFPM2 KIF3B	2.94e-03	16	150	2	EFO_0008104
Disease	Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	UBR5 ATM	2.94e-03	16	150	2	C0334634
Disease	monocyte count	COL4A2 FXR2 BAZ2B INPP5D CDH23 DIDO1 EIF2S3B ZFPM2 CAPN10 HIVEP3 KIF3B ATM CABIN1 MARCKS RAI1	3.05e-03	1320	150	15	EFO_0005091
Disease	fibrinogen measurement, factor VII measurement	SHANK3 PARD3 HDLBP	3.24e-03	58	150	3	EFO_0004619, EFO_0004623
Disease	Benign neoplasm of stomach	UBR5 ATM	3.32e-03	17	150	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	UBR5 ATM	3.32e-03	17	150	2	C0496905
Disease	Carcinoma in situ of stomach	UBR5 ATM	3.32e-03	17	150	2	C0154060
Disease	Carcinoma of bladder	ATM STAG2	3.72e-03	18	150	2	C0699885
Disease	PR interval	ITGA9 ZFPM2 HIVEP3 THBS1 OTUD7A ALPK3 KIAA1755 MARCKS	3.93e-03	495	150	8	EFO_0004462
Disease	Obesity	CYP1B1 IRS1 PLIN1 HSPA5 RAI1	4.04e-03	205	150	5	C0028754
Disease	FEV/FEC ratio	COL4A2 CYP1B1 STRBP SOX30 CDH23 GTF2IRD1 FAM83H HIVEP3 FCGBP KIF3B PARD3 TNXB CUX1 HDLBP	4.06e-03	1228	150	14	EFO_0004713
Disease	Hereditary Non-Polyposis Colon Cancer Type 2	PALB2 ATM	4.15e-03	19	150	2	C1333991
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	PALB2 ATM	4.15e-03	19	150	2	C2936783
Disease	Coronary Arteriosclerosis	IRS1 ADAMTS7 MMP3	4.47e-03	65	150	3	C0010054
Disease	Coronary Artery Disease	IRS1 ADAMTS7 MMP3	4.47e-03	65	150	3	C1956346
Disease	Adenocarcinoma of prostate	PALB2 ATM	4.59e-03	20	150	2	C0007112
Disease	Microcephaly	PCDH12 STAG2 FOXG1	4.86e-03	67	150	3	C0025958
Disease	MYELODYSPLASTIC SYNDROME	PALB2 STAG2 CUX1	4.86e-03	67	150	3	C3463824
Disease	venous thromboembolism, fibrinogen measurement	SHANK3 ZFPM2 HDLBP	4.86e-03	67	150	3	EFO_0004286, EFO_0004623
Disease	Stomach Carcinoma	UBR5 ATM	5.06e-03	21	150	2	C0699791

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLPDDDPEAGQGSKF	ARNT	321	P27540
GVIARGDKDFPPAAA	DAP	61	P51397
VDFGGAEPQEKAPRS	BDP1	56	A6H8Y1
GDPTVGQAKDFLEPL	ADAL	181	Q6DHV7
NPPDAKGSRDLVDGI	NEDD9	351	Q14511
DPKEPADLVAIAFGG	ALLC	191	Q8N6M5
ANAGRPLFPGNDVDD	CDK5	196	Q00535
KEAQDAPGLDPQGAA	CUX1	786	P39880
KGRPPNVGNAEFLDN	BAZ2B	866	Q9UIF8
EAGRAGAAPVAPEKQ	ARHGEF2	786	Q92974
GADPNIADQDGKRPL	ASB10	171	Q8WXI3
QEEKFPGEALTGLPA	ALPK3	1341	Q96L96
GQKGEPYALPKEERD	COL4A2	166	P08572
AGPNLEGDFKGPKVD	AHNAK	3436	Q09666
GPKVDINAPDVDVRG	AHNAK	3911	Q09666
FKGEGPDVDVNLPKA	AHNAK	4201	Q09666
FPDDPREGQVKQGLL	CAPN10	56	Q9HC96
QDPAERPDFGQIKGF	NPR2	771	P20594
QDRAEAPKAESGEPG	CACNA1B	866	Q00975
GTFGREPAAVKPDDD	CDH23	3171	Q9H251
PQDDPKREGGIDYQA	CDK13	1311	Q14004
EVFKDDEEPKGRGAP	ADAMTS7	1216	Q9UKP4
IIFDGDDKQPEAPGT	CHML	616	P26374
LGFQEEDPPGEKVAS	RAI1	791	Q7Z5J4
QFPDGVDVRVPGFGK	PLA2G15	106	Q8NCC3
PDQGPNGEVEFFLSK	PCDH12	271	Q9NPG4
LDPNGEGPKATVDLD	KASH5	81	Q8N6L0
PPESEGFGDRLFLKQ	ANKRD27	371	Q96NW4
GEAGKPKFGIEPNAE	FKBP5	226	Q13451
FGEPDRVGPQKFLSA	NFATC2	86	Q13469
GKLPGQERPSDDHFV	PATL1	571	Q86TB9
PLFEKQDREGPASTG	FAM171A1	496	Q5VUB5
LAEQRDTGLGDKPFP	MAP1A	546	P78559
PQDLEGPGRAESKES	MAP1S	461	Q66K74
ESRGLPVPQAEGEKD	MAGEF1	6	Q9HAY2
ESEKREEPNRAGPGD	FXR2	456	P51116
AAGEERVPKPGEQDL	DNAAF2	426	Q9NVR5
GGQKRPLEDGDQPDA	FUBP1	61	Q96AE4
AALVPPNFGEKEGKE	FAM90A1	66	Q86YD7
PERAKEENGGQPRAA	GPR158	1096	Q5T848
PPQEAGQAAEAEDGK	KIAA1755	1126	Q5JYT7
DLGQLDGKVFPNPES	ZFPM2	886	Q8WW38
GFPKQIAEDFPGIDS	MMP3	421	P08254
PVEDQREGLEAAPKG	EPSTI1	36	Q96J88
QTRGAPAADDDKGPQ	FOXG1	86	P55316
GSPGDSPEENKERVE	MYLK3	151	Q32MK0
ELGPEADQPEAAKFR	NOL6	566	Q9H6R4
GAEGPQEPKEAADRA	EHBP1L1	1186	Q8N3D4
EFQKGHPDLQGQPAE	LMAN1	306	P49257
GGQPFSEVGEVKDFP	GGA2	591	Q9UJY4
HVFNEGRGPKQPERE	OTUD7A	76	Q8TE49
RELGDFTPHDNEPGK	PAXBP1	236	Q9Y5B6
FKHTQRPGEPEEGAR	IRS1	771	P35568
EGEEGQPRQLTPFEK	NIM1K	36	Q8IY84
VQAPAEPAAGKAEQG	IQSEC3	516	Q9UPP2
LGEARPEDAGAPFEQ	EPS8L2	546	Q9H6S3
DGSKNDDRAGPPRFA	MED30	121	Q96HR3
ENKFSEVAALPGPRG	PLIN1	316	O60240
EEGNPVRGSEEDSPK	HTATSF1	486	O43719
EAAPGQGQAAVKAEP	HOXB9	106	P17482
PPGQAGRFLEGDVKD	PALB2	1111	Q86YC2
NPFEDDFGAPKVGVA	PYGO2	76	Q9BRQ0
YGQGLEDLEAKAPPR	OPN4	441	Q9UHM6
NDGFPDVAIGAPKED	ITGA9	376	Q13797
VQAENDFGKGPEPES	NFASC	801	O94856
SRFEEPKGPPARQED	CBY2	306	Q8NA61
EVPRFDKENPFEGLD	ATM	1776	Q13315
ISANAGEPGPKRDEE	CACNG8	181	Q8WXS5
FGPPNGSVKDDRDLQ	HIP1R	341	O75146
KGEFGVEDDRPARGP	GCC1	111	Q96CN9
EGPFARGEEKNTPKA	CABIN1	1296	Q9Y6J0
NEEAERKGGPPFLSF	C2CD2	86	Q9Y426
EAQAGNDPFLKGIPE	GNGT2	41	O14610
GFSKEGAAEPEPQSL	FAM193B	581	Q96PV7
QDPADDLKAVGGKPA	FCGBP	2216	Q9Y6R7
IKRLFPGQPAEENGA	FRMPD2	1111	Q68DX3
FQGADRPGPEEKREE	CRACD	471	Q6ZU35
PPGFKARGTAEDEER	GPALPP1	11	Q8IXQ4
RGSEAINAPGDNPAK	C1RL	176	Q9NZP8
GVAPSQFEERKDPHG	DIDO1	1836	Q9BTC0
PEEQGELEPLKGNFD	FOXJ1	296	Q92949
AGDPLDSKRGEAPFA	COA3	6	Q9Y2R0
ADEKNGAQTRPAGAP	BRSK1	726	Q8TDC3
NVKFRNPPGGDNLEE	TMEM30A	211	Q9NV96
NPPGGDNLEERFKGT	TMEM30A	216	Q9NV96
TERGASDQEPGAKEP	DRGX	91	A6NNA5
GGDPQEAKPQEAAVA	MARCKS	231	P29966
GEPEDDEAPAKGKFN	LYAR	296	Q9NX58
FEKEGDQGPNIIPAD	DNAJB13	196	P59910
KEAGNIESGVEPPDR	EFHB	231	Q8N7U6
NPENFDPARFLDKDG	CYP1B1	436	Q16678
ARPFPDGLAEDIDKG	EEF2	606	P13639
GNGFRAKPPGAAEEA	FIGNL2	306	A6NMB9
PKPGEAAAAVEGQRQ	EN2	6	P19622
DEFPTDIPGTKGNFR	EIF2S3B	111	Q2VIR3
QDFSKVVPPLDEDGR	CDK2	246	P24941
GPEEPGLAKQDSFRS	FAM83H	656	Q6ZRV2
FQGLIPKPDEDDANR	GTF2IRD1	781	Q9UHL9
GKEPSRGINPDEAVA	HSPA5	381	P11021
VEAGEVDPDPGNNKL	GJB3	246	O75712
DERISQGPKEPQGFH	POLI	631	Q9UNA4
EKPVAQEPERIEFGG	RSF1	341	Q96T23
TPFGADQVKDRGPEA	SLC15A4	176	Q8N697
GKEAPEEAQLDRPGQ	SLC38A10	471	Q9HBR0
RLPKFVDVQPNDGFG	CFAP74	956	Q9C0B2
AKEAKGGVPEEARPA	DCAF15	331	Q66K64
PEGTRNDNGDLLPFK	AGPAT2	171	O15120
VDDQKAGSPSRDVGP	PARD3	866	Q8TEW0
EEKGDPNKPSGFRSV	PDLIM1	226	O00151
KGNDLFSPDEEGPAV	MSX2	6	P35548
GSAKRSQPEPGVADE	RPP25	181	Q9BUL9
TPGPDAGAQDEAKEQ	MACROD2	406	A1Z1Q3
TDGPGLKRPASQDFE	NRK	1086	Q7Z2Y5
PNGEKPDEFESGISQ	RPS7	11	P62081
GNFEEIGPLDSDLKP	SCPEP1	86	Q9HB40
PNTETNGEFGKRPAE	HNRNPK	11	P61978
QEADRGEGPGKQVPA	INPP5D	1066	Q92835
AGPEEAKAPVRGDEA	SH3TC1	46	Q8TE82
KRPFEDGLGDDKDPN	STRBP	356	Q96SI9
DRKEGGDEQQEAPPG	RNF217	116	Q8TC41
FAQGVNPLPDEDGLD	STARD9	3226	Q9P2P6
KEPEPFGASAAGLEQ	NINL	921	Q9Y2I6
AGFPPDQRNGDKEFV	RASGRF1	931	Q13972
DAGIPDTPFSKDRNG	SOX30	321	O94993
LQPQGDEDPGKFKEA	TBC1D9B	126	Q66K14
FVKPDGENRARFLPG	CCDC146	731	Q8IYE0
PEDNDGFKPPREHLN	SETDB2	516	Q96T68
RLVPNPDQKDSDGDG	THBS1	911	P07996
ELVKEPLSNDGAAPG	VPS11	16	Q9H270
QDEPAAAAGPGKGRF	ZCCHC3	151	Q9NUD5
AEQEKDAPLGGAAIP	STBD1	36	O95210
FQPPSRGRAGKFLDE	SHANK3	56	Q9BYB0
DGIEFAFKEPNPQGE	STAG2	976	Q8N3U4
GDPEKRGVIPNSFDH	KIF3B	111	O15066
EGQPRAAEKRPAGDY	TCEAL6	91	Q6IPX3
VFPDEQLSDGENGIP	TTBK2	346	Q6IQ55
YKDRDGQPQVVPVEG	TNXB	1096	P22105
SGLEGEDKPLAQFPS	HIVEP3	816	Q5T1R4
SAGTRPGDVKEEAPQ	ZBTB4	806	Q9P1Z0
SEQLFEDPDPGGKSQ	TMCC1	6	O94876
EDPDPGGKSQDAEAR	TMCC1	11	O94876
EQNPGKFEELERAPG	TBC1D10B	381	Q4KMP7
QEKEAAGGFPPAESR	TACC2	226	O95359
GGEQKEPESRDALPF	ZNF518A	1181	Q6AHZ1
QEGHFRPGIDPQEKS	ZNF264	136	O43296
HGPAEEQSKDGNEPR	ULK2	626	Q8IYT8
ADEDGFVAPQDPLRG	ZNF236	846	Q9UL36
GVGPPANEDTREKAA	SNAPC4	156	Q5SXM2
DLKNRRGGPPFAFVE	SRSF1	46	Q07955
QEGGEAAKAAPEEPQ	ZFP91	16	Q96JP5
EFKVDIRFPQSGAPD	HDLBP	1156	Q00341
VPSEKDPAQFRDPGA	PRR30	196	Q53SZ7
PGGVQARLEKDAAAP	TTLL10	246	Q6ZVT0
GPAALAEDKSEAQGP	TUB	136	P50607
LNGKRSSEGESPDFP	VIP	151	P01282
GFSVQPDRLELGKPD	UBR5	71	O95071
RGPAPGEEKFENLEG	ZNF263	291	O14978
DAPSPAQENGEKGEF	NARF	26	Q9UHQ1
ARFKGFPQPILSEDG	MYOF	1681	Q9NZM1